Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1.518 JPY | -1,68 % | -5,12 % | -12,71 % |
Resumen de negocios
Número de empleados: 1 621
Ventas por actividad
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Product - Hormones
39,3
%
| 12 073 | 34,1 % | 16 047 | 39,3 % | +32,92 % |
Product - Others
24,1
%
| 9 032 | 25,5 % | 9 846 | 24,1 % | +9,01 % |
Product - Diagnostic Agent
18,8
%
| 7 447 | 21,0 % | 7 672 | 18,8 % | +3,02 % |
Product - Metabolic Drugs
5,0
%
| 1 486 | 4,2 % | 2 056 | 5,0 % | +38,36 % |
Merchandise - Others
3,4
%
| 930 | 2,6 % | 1 409 | 3,4 % | +51,51 % |
Product - Tissue Cell Function Drug
2,5
%
| 948 | 2,7 % | 1 010 | 2,5 % | +6,54 % |
Merchandise - Hormones
2,3
%
| 1 227 | 3,5 % | 925 | 2,3 % | -24,61 % |
Product - Nervous System and Sensory Organ Agents
1,8
%
| 924 | 2,6 % | 749 | 1,8 % | -18,94 % |
Product - Antibiotics and Chemotherapeutic Agents
1,5
%
| 651 | 1,8 % | 630 | 1,5 % | -3,23 % |
Product - Cardiovascular Drugs
1,0
%
| 553 | 1,6 % | 409 | 1,0 % | -26,04 % |
Merchandise - In-vitro Diagnostics Drugs
0,3
%
| 149 | 0,4 % | 130 | 0,3 % | -12,75 % |
Ventas por región
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| 35 426 | 100,0 % | 40 889 | 100,0 % | +15,42 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Takayuki Iwai
PSD | President | 60 | 01/12/06 |
Hirofumi Imai
CHM | Chairman | 60 | 01/04/87 |
Hiroshi Uji
ADM | Chief Administrative Officer | - | - |
Toyoyuki Kamide
BRD | Director/Board Member | 59 | 01/04/00 |
Takanori Matsuo
SAM | Sales & Marketing | - | - |
Shuhei Morita
PRN | Corporate Officer/Principal | - | - |
Seiichi Inoue
AUD | Comptroller/Controller/Auditor | 65 | 01/04/14 |
Corporate Officer/Principal | 53 | 01/04/94 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Vilhelm Wessman
BRD | Director/Board Member | 54 | 01/11/18 |
Keiji Hirai
BRD | Director/Board Member | 74 | 01/12/16 |
Director/Board Member | 71 | 01/12/17 | |
Hirofumi Imai
CHM | Chairman | 60 | 01/04/87 |
Toyoyuki Kamide
BRD | Director/Board Member | 59 | 01/04/00 |
Tadahiro Kozawa
BRD | Director/Board Member | 74 | 01/10/93 |
Seiichi Inoue
AUD | Comptroller/Controller/Auditor | 65 | 01/04/14 |
Takayuki Iwai
PSD | President | 60 | 01/12/06 |
Yukiko Araki
BRD | Director/Board Member | 63 | 01/12/20 |
Keiko Kiyama
BRD | Director/Board Member | 64 | 01/12/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 24 753 800 | 12 606 585 ( 50,93 %) | 441 500 ( 1,784 %) | 50,93 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
ALVOTECH 1.68% | 4 475 691 | 1.68% | 61 093 182 $ |
4 913 220 | 1.85% | 48 736 882 $ | |
FUJI PHARMA CO., LTD. 1.75% | 433 400 | 1.75% | 4 379 030 $ |
Información de la empresa
Fuji Pharma Co., Ltd.
Seito Kaikan, 6/F 5-7 Sanban-cho
102-0075, Tokyo
+81 3 3556 3344
http://www.fujipharma.jpVentas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-12,71 % | 240 M | |
+29,98 % | 682 mil M | |
+32,39 % | 586 mil M | |
-3,52 % | 364 mil M | |
+18,59 % | 327 mil M | |
+4,07 % | 285 mil M | |
+16,50 % | 240 mil M | |
+9,56 % | 209 mil M | |
-9,04 % | 203 mil M | |
+7,09 % | 165 mil M |
- Bolsa de valores
- Acciones
- Acción 4554
- Empresa Fuji Pharma Co., Ltd.